Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic
Glaucoma is the leading cause of irreversible blindness worldwide, with primary open angle glaucoma (POAG) accounting for the greatest number of total glaucoma cases. This study aimed to evaluate the efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) as a primary procedu...
Main Authors: | Hsiao-Ling Chang, Shih-Chun Chao, Ming-Tsung Lee, Hung-Yu Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/9/11/1563 |
Similar Items
-
Micropulse transscleral diode laser cyclophotocoagulation as a treatment modality for glaucoma patients
by: Gehad H.A Youssef, et al.
Published: (2022-01-01) -
Micropulse Transscleral Cyclophotocoagulation for Glaucoma after Penetrating Keratoplasty
by: Mihail Zemba, et al.
Published: (2022-05-01) -
Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation Use in Refractory Glaucoma Patients
by: Elsa Gustianty, et al.
Published: (2022-09-01) -
Micropulse transscleral diode laser cyclophotocoagulation in the treatment of congenital glaucoma. Case report
by: T. V. Sokolovskaya, et al.
Published: (2019-11-01) -
Micropulse transscleral cyclophotocoagulation (MP-CPC): efficacy endpoints for the treatment of refractory paediatric glaucoma - a retrospective case-series
by: Nasser Balbaid, et al.
Published: (2024-02-01)